Dr Martens has appointed its non-executive director Ije Nwokorie to the newly created role of chief brand officer, effective from February 1, 2024.

HR-2708

Ije Nwokorie will become chief brand officer from February 2023 

Nwokorie joins Dr Martens from Apple, where he has been a senior director since January 2018. He was formerly chief executive at global brand consultancy Wolff Olins and is currently chair of the non-profit organisation Water UK.

Dr Martens said Nwokorie will be a “key member” of its global leadership team, responsible for “setting the overall brand strategy, vision and direction” for the next phase of the fashion retailer’s growth.

Nwokorie will report to chief executive Kenny Wilson and “cease to be a member of the board” from next year, as well as stepping down as a member of the audit and risk, nomination and disclosure committees when he starts his new role.

Wilson said: “Ije is a visionary brand storyteller and this, along with his infectious passion for Dr Martens, makes him the ideal person to lead the next era of our brand development.

“I am delighted that he will be joining my team in a permanent full-time position of chief brand officer, which will be a crucial role to enable us to become a £2bn revenue brand.”

Chair Paul Mason said: “Ije has been a tremendous non-executive director since he joined the board in January 2021. He has deep insight and understanding of brands and has extensive global DTC experience.

”I am delighted that he’ll be joining the leadership team as chief brand officer, a role for which he is perfectly suited.”

Nwokorie added: “I’ve always loved Dr Martens and it’s been a real privilege getting to know the brand from the inside as a non-executive director.

“Dr Martens is defined by its rebellious, authentic and creative nature, all of which makes me really excited to be joining Kenny and the team early in the new year and to get to work.”

This follows the fashion retailer’s appointment earlier this week of Giles Wilson as its new chief financial officer.